Accenture Cash & Equivalents decreased by 2.6% to $9.40B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $8.49B to $9.40B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows an upward trend with a 6.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.01B | $8.17B | $5.64B | $5.47B | $6.70B | $7.89B | $5.90B | $6.24B | $8.54B | $9.05B | $7.14B | $5.12B | $5.54B | $5.00B | $8.31B | $8.49B | $9.63B | $11.48B | $9.65B | $9.40B |
| QoQ Change | — | -18.4% | -31.0% | -3.0% | +22.6% | +17.7% | -25.2% | +5.7% | +36.8% | +6.0% | -21.1% | -28.3% | +8.1% | -9.6% | +66.0% | +2.2% | +13.4% | +19.2% | -15.9% | -2.6% |
| YoY Change | — | — | — | — | -33.0% | -3.4% | +4.7% | +14.1% | +27.3% | +14.6% | +21.0% | -17.9% | -35.1% | -44.7% | +16.3% | +65.8% | +73.9% | +129.4% | +16.2% | +10.7% |